S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Get Rid of Your Siri Remote Once and for All This Year
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
No OPEC+ oil shakeup as Russian price cap stirs uncertainty
OPEC doesn't change its targets for oil production amid uncertainty over new Western price cap on Russian oil
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
As Musk is learning, content moderation is a messy job
Reformers take 6 of 14 UAW board seats, could win majority
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
FDA change ushers in cheaper, easier-to-get hearing aids
OPEC keeps oil targets amid uncertainty on Russian sanctions
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Get Rid of Your Siri Remote Once and for All This Year
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
No OPEC+ oil shakeup as Russian price cap stirs uncertainty
OPEC doesn't change its targets for oil production amid uncertainty over new Western price cap on Russian oil
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
As Musk is learning, content moderation is a messy job
Reformers take 6 of 14 UAW board seats, could win majority
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
FDA change ushers in cheaper, easier-to-get hearing aids
OPEC keeps oil targets amid uncertainty on Russian sanctions
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Get Rid of Your Siri Remote Once and for All This Year
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
No OPEC+ oil shakeup as Russian price cap stirs uncertainty
OPEC doesn't change its targets for oil production amid uncertainty over new Western price cap on Russian oil
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
As Musk is learning, content moderation is a messy job
Reformers take 6 of 14 UAW board seats, could win majority
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
FDA change ushers in cheaper, easier-to-get hearing aids
OPEC keeps oil targets amid uncertainty on Russian sanctions
S&P 500   4,071.70
DOW   34,429.88
QQQ   292.55
Get Rid of Your Siri Remote Once and for All This Year
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
No OPEC+ oil shakeup as Russian price cap stirs uncertainty
OPEC doesn't change its targets for oil production amid uncertainty over new Western price cap on Russian oil
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
As Musk is learning, content moderation is a messy job
Reformers take 6 of 14 UAW board seats, could win majority
🚨 [Strong Buy Alert] Is this laser stock in your portfolio? (Ad)
FDA change ushers in cheaper, easier-to-get hearing aids
OPEC keeps oil targets amid uncertainty on Russian sanctions
NYSE:GMRE

Global Medical REIT - GMRE Stock Forecast, Price & News

$10.20
+0.15 (+1.49%)
(As of 12/2/2022 12:00 AM ET)
Add
Compare
Today's Range
$9.88
$10.21
50-Day Range
$7.16
$10.20
52-Week Range
$7.01
$18.51
Volume
716,004 shs
Average Volume
607,003 shs
Market Capitalization
$668.30 million
P/E Ratio
40.80
Dividend Yield
8.24%
Price Target
$16.50

Global Medical REIT MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
61.8% Upside
$16.50 Price Target
Short Interest
Healthy
11.80% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.19
Upright™ Environmental Score
News Sentiment
0.40mentions of Global Medical REIT in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.17%
From $0.92 to $0.94 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Finance Sector

289th out of 891 stocks

Real Estate Investment Trusts Industry

68th out of 192 stocks

GMRE stock logo

About Global Medical REIT (NYSE:GMRE) Stock

Global Medical REIT Inc. is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.

Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Stock News Headlines

JMP Securities Reaffirms Their Hold Rating on Global Medical REIT (GMRE)
Global Medical REIT (GMRE) Q3 FFO Lag Estimates
GMRE.PA Global Medical REIT Inc. 7.50% CUM PFD A
Global Medical REIT Now Has A 9% Recession Resistant Yield
Flying Under The Radar: 3 Small-Cap Healthcare REIT Gems
Short Volatility Alert: Global Medical REIT Inc.
3 Health Care REITs To Help You Sleep Well At Night
Summit Hotel Properties (INN) Misses Q2 FFO Estimates
SL Green (SLG) Q2 FFO Surpass Estimates
See More Headlines
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 10/11 Dividend
9/22/2022
Dividend Payable
10/11/2022
Today
12/04/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.50
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+61.8%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.62 million
Pretax Margin
18.00%

Debt

Sales & Book Value

Annual Sales
$115.94 million
Cash Flow
$1.04 per share
Book Value
$9.00 per share

Miscellaneous

Free Float
60,539,000
Market Cap
$668.30 million
Optionable
Optionable
Beta
1.03

Key Executives

  • Mr. Jeffery M. BuschMr. Jeffery M. Busch (Age 62)
    Chairman, Pres & CEO
    Comp: $966.79k
  • Mr. Robert J. Kiernan CPA (Age 56)
    CFO & Treasurer
    Comp: $539.79k
  • Ms. Danica C. Holley (Age 49)
    Chief Operating Officer
    Comp: $378.26k
  • Mr. Alfonzo Leon (Age 46)
    Chief Investment Officer
    Comp: $499.51k
  • Mr. Jamie A. Barber (Age 45)
    Gen. Counsel & Corp. Sec.
    Comp: $372.26k
  • Ms. Mary Jensen
    Investor Relations Professional













GMRE Stock - Frequently Asked Questions

Should I buy or sell Global Medical REIT stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last twelve months. There are currently 3 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" GMRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GMRE, but not buy additional shares or sell existing shares.
View GMRE analyst ratings
or view top-rated stocks.

What is Global Medical REIT's stock price forecast for 2023?

3 brokerages have issued twelve-month target prices for Global Medical REIT's shares. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they predict the company's stock price to reach $16.50 in the next year. This suggests a possible upside of 61.8% from the stock's current price.
View analysts price targets for GMRE
or view top-rated stocks among Wall Street analysts.

How have GMRE shares performed in 2022?

Global Medical REIT's stock was trading at $17.75 at the start of the year. Since then, GMRE shares have decreased by 42.5% and is now trading at $10.20.
View the best growth stocks for 2022 here
.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a decline in short interest in November. As of November 15th, there was short interest totaling 1,800,000 shares, a decline of 9.5% from the October 31st total of 1,990,000 shares. Based on an average trading volume of 681,500 shares, the short-interest ratio is presently 2.6 days. Approximately 11.8% of the company's stock are sold short.
View Global Medical REIT's Short Interest
.

When is Global Medical REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our GMRE earnings forecast
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) announced its earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a trailing twelve-month return on equity of 3.76% and a net margin of 16.48%. During the same period in the prior year, the company posted $0.24 EPS.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT announced a quarterly dividend on Friday, September 9th. Investors of record on Friday, September 23rd will be paid a dividend of $0.21 per share on Tuesday, October 11th. This represents a $0.84 annualized dividend and a yield of 8.24%. The ex-dividend date is Thursday, September 22nd.
Read our dividend analysis for GMRE
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 8.24%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 336.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 89.36% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at a price of $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (9.67%), BlackRock Inc. (7.25%), State Street Corp (2.82%), Nuveen Asset Management LLC (2.72%), Brown Advisory Inc. (1.90%) and Royal Bank of Canada (1.88%). Insiders that own company stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends
.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $10.20.

How much money does Global Medical REIT make?

Global Medical REIT (NYSE:GMRE) has a market capitalization of $668.30 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.25 on an earnings per share basis.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The official website for the company is www.globalmedicalreit.com. The company can be reached via phone at (202) 524-6851 or via email at investors@globalmedicalreit.com.

This page (NYSE:GMRE) was last updated on 12/4/2022 by MarketBeat.com Staff